Category Archives: Cancer and neoplasms

Streamlined Referral Intervention Sees Great Success Among Patients With Head/Neck Cancer

Joelle Hicks, BSN, RN, Summa Health Cancer Institute Between January 1 and December 31, 2022, 100% of patients with head and neck cancer undergoing radiation treatment at Summa Health Cancer Institute in Ohio were referred to an oncology dietician to receive ongoing nutritional support plus speech and swallow therapy to manage the adverse effects (AEs) […]

Dr Joseph Chervenak Discusses How Large Language Models Are Revolutionizing Reproductive Care

Personalized information tailored to recommended reading levels through large language models can address socioeconomic barriers when it comes to receiving reproductive care and improving patient outcomes, says Joseph Chervenak, MD, MBA, obstetrician and gynecologist at Montefiore Institute for Reproductive Medicine and Health. Transcript You are presenting on the topic of “Patient Centric & Access to […]

Progress in Male Contraception: An Unmet Need in an Epidemic of Unplanned Pregnancy

Tablet for Potency | Image Credit: adragan – stock.adobe.com Programs dedicated to male reproduction and the development of effective, reversible hormonal contraceptives are potential game changers in family planning, explained Stephanie Page, MD, PhD, University of Washington, in a presentation at the American Society of Reproductive Medicine 2023 Scientific Congress & Expo, held in New […]

Powered by Its Industry-Leading Comprehensive Multi-Omic Database, Caris Life Sciences to Showcase Research at ESMO 2023

In collaboration with leading cancer centers, research results to be presented from seven studies across a breadth of tumor types and genomic alterations demonstrating Caris’ impact on precision medicine IRVING, Texas, Oct. 17, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering […]

Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress …

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will host a live webcast at 8:00 a.m. ET / 2:00 p.m. CEST on Monday, October 23, 2023 to review interim monotherapy data from its Phase 1/2 clinical […]

Women Leaders in Oncology® Presents “Woman Oncologist of the Year” Award to Dr. Julie Gralow, “Rising Star” Award to Dr. Jaydira Del Rivero

— Awards presented at the 5th Annual LEAD conference for women in oncology and hematology — SCOTTSDALE, Ariz., Oct. 16, 2023 /PRNewswire/ — This past weekend, Women Leaders in Oncology® (WLO) presented its “Woman Oncologist of the Year” award to Julie Gralow, MD, FACP, FASCO, Chief Medical Officer and Executive Vice President of the American Society of […]

Ascentage Pharma and AstraZeneca Enter into Clinical Collaboration on the Registrational Phase III Study of Bcl-2 Inhibitor Lisaftoclax in Combination with BTK Inhibitor Acalabrutinib in Treatment-Naïve Patients with First-Line CLL/SLL

SUZHOU, China, and ROCKVILLE, Md., Oct. 15, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has entered into a clinical collaboration with AstraZeneca Investment (China) Co., Ltd. (or “AstraZeneca”). The two companies will jointly conduct […]

Harpoon Therapeutics to Host Webcast Reviewing HPN328 Interim Data Presented at ESMO Congress 2023 on October 23, 2023

SOUTH SAN FRANCISCO, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced that it will host a live webcast at 8:00 a.m. ET / 2:00 p.m. CEST on Monday, October 23, 2023 to review interim monotherapy data from its Phase 1/2 clinical […]